VERTEX PHARMACEUTICALS INCORPORATED Funds and ETFs Vertex Pharmaceuticals Incorporated
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 429.9 USD | +1.69% |
|
+6.81% | +5.66% |
| 05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
| 05-07 | FOMO is Back |  |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 322 M€ | +13.88% | ||
| 0.13% | 29 M€ | -.--% | - | |
| 0.13% | 1 M€ | +3.03% | - | |
| 0.12% | 34 M€ | +8.24% | - | |
| 0.11% | 104 M€ | +8.99% | ||
| 0.11% | 391 M€ | +8.67% | - | |
| 0.09% | 45 M€ | 0.00% | - | |
| 0.09% | 306 M€ | +5.68% | - | |
| 0.09% | 39 M€ | +5.63% | - | |
| 0.08% | 756 M€ | -0.24% | - | |
| 0.08% | 2 M€ | +3.16% | - | |
| 0.06% | 12 M€ | +11.92% | - | |
| 0.05% | 6 M€ | +3.89% | ||
| 0.05% | 105 M€ | +3.54% | - | |
| 0.05% | 17 M€ | +2.80% | - | |
| 0.04% | 112 M€ | +4.06% | - | |
| 0.04% | 32 M€ | +0.82% | - | |
| 0.03% | 54 M€ | +0.54% | - | |
| 0.03% | 8 M€ | +0.50% | - | |
| 0.02% | 234 M€ | +2.60% | - | |
| 0.02% | 6 M€ | -4.26% | - | |
| 0.01% | 169 M€ | -0.77% | - | |
| 7.21% | 129 M€ | +6.62% | - | |
| 8.05% | 28 M€ | +5.19% | - |
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Calendar
2024-05-15
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
422.8
USD
Average target price
462.1
USD
Spread / Average Target
+9.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.66% | 109B | |
| +11.23% | 105B | |
| -0.38% | 22.25B | |
| -12.15% | 22.09B | |
| -7.66% | 18.68B | |
| -36.52% | 17.58B | |
| -10.09% | 16.85B | |
| +3.33% | 13.76B | |
| +36.58% | 12.46B | |
| +288.77% | 8.12B |
- Stock Market
- Equities
- VRTX Stock
- Funds and ETFs Vertex Pharmaceuticals Incorporated